Quick Answer
XBiotech Inc. reported Cash And Cash Equivalents At Carrying Value of $125.55 million for the year ending 2025.
- XBiotech Inc. showed a decrease of -27.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from XBiotech Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), XBiotech Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,913.0%.
- Historical annual values: Fiscal year 2025: $125.55 million | Fiscal year 2024: $172.68 million | Fiscal year 2023: $200.02 million | Fiscal year 2022: $157.31 million | Fiscal year 2021: $236.98 million | Fiscal year 2020: $237.37 million | Fiscal year 2019: $714.59 million | Fiscal year 2018: $15.82 million | Fiscal year 2017: $31.77 million | Fiscal year 2016: $34.32 million | Fiscal year 2015: $91.05 million | Fiscal year 2014: $57.33 million | Fiscal year 2013: $7.24 million | Fiscal year 2012: $4.17 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: